Important Dates
Early Bird Registration :19th May 2027
Paper Submission Deadline :24th May 2027
Last Date of Registration : 3rd June 2027
Date of Conference : 18th - 19th June 2027
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
Track 01
Genomic Variation and Disease Mechanisms
This track focuses on the relationship between genomic variations and the underlying mechanisms of various diseases. Discussions will include how specific mutations and structural variants contribute to disease pathology.
Track 02
SNP Analysis and Disease Susceptibility
This session will delve into single nucleotide polymorphisms (SNPs) and their role in influencing disease susceptibility. Researchers will present findings on SNP associations with various health conditions.
Track 03
Copy Number Variation and Its Implications
This track will explore the impact of copy number variations (CNVs) on genetic predisposition to diseases. Presentations will highlight recent discoveries linking CNVs to specific phenotypic outcomes.
Track 04
Structural Variants in Human Genomics
This session will address the significance of structural variants in the human genome and their association with complex diseases. Researchers will discuss methodologies for detecting and characterizing these variants.
Track 05
Mutation Mapping and Disease Associations
This track will focus on advanced techniques for mutation mapping and their applications in identifying disease-associated variants. Participants will share insights on the integration of mutation data into clinical practice.
Track 06
Genome-Wide Association Studies (GWAS) Advances
This session will cover the latest advancements in genome-wide association studies and their implications for understanding disease susceptibility. Researchers will present novel findings and methodologies in GWAS.
Track 07
Risk Alleles and Population Genomics
This track will investigate the role of risk alleles in population genomics and their impact on public health. Discussions will include the identification and distribution of risk alleles across diverse populations.
Track 08
Functional Genomics and Disease Mechanisms
This session will explore the application of functional genomics in elucidating disease mechanisms. Presenters will discuss how functional studies can enhance our understanding of genetic contributions to disease.
Track 09
Genotype-Phenotype Correlation Studies
This track will focus on the correlation between genotype and phenotype in various diseases. Researchers will present case studies that illustrate the clinical relevance of these correlations.
Track 10
Rare Variants and Their Clinical Significance
This session will address the identification and clinical implications of rare genetic variants in disease susceptibility. Discussions will include challenges in studying rare variants and their potential as biomarkers.
Track 11
Personalized Medicine and Genomic Profiling
This track will explore the role of genomic profiling in personalized medicine approaches. Presentations will highlight how genomic data can inform tailored therapeutic strategies for disease management.